Unknown

Dataset Information

0

Identification of quercitrin as an inhibitor of the p90 S6 ribosomal kinase (RSK): structure of its complex with the N-terminal domain of RSK2 at 1.8 A resolution.


ABSTRACT: Members of the RSK family of kinases constitute attractive targets for drug design, but a lack of structural information regarding the mechanism of selective inhibitors impedes progress in this field. The crystal structure of the N-terminal kinase domain (residues 45-346) of mouse RSK2, or RSK2(NTKD), has recently been described in complex with one of only two known selective inhibitors, a rare naturally occurring flavonol glycoside, kaempferol 3-O-(3'',4''-di-O-acetyl-?-L-rhamnopyranoside), known as SL0101. Based on this structure, it was hypothesized that quercitrin (quercetin 3-O-?-L-rhamnopyranoside), a related but ubiquitous and inexpensive compound, might also act as an RSK inhibitor. Here, it is demonstrated that quercitrin binds to RSK2(NTKD) with a dissociation constant (K(d)) of 5.8 µM as determined by isothermal titration calorimetry, and a crystal structure of the binary complex at 1.8 Å resolution is reported. The crystal structure reveals a very similar mode of binding to that recently reported for SL0101. Closer inspection shows a number of small but significant differences that explain the slightly higher K(d) for quercitrin compared with SL0101. It is also shown that quercitrin can effectively substitute for SL0101 in a biological assay, in which it significantly suppresses the contractile force in rabbit pulmonary artery smooth muscle in response to Ca(2+).

SUBMITTER: Derewenda U 

PROVIDER: S-EPMC3565440 | biostudies-literature | 2013 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of quercitrin as an inhibitor of the p90 S6 ribosomal kinase (RSK): structure of its complex with the N-terminal domain of RSK2 at 1.8 Å resolution.

Derewenda Urszula U   Artamonov Mykhaylo M   Szukalska Gabriela G   Utepbergenov Darkhan D   Olekhnovich Natalya N   Parikh Hardik I HI   Kellogg Glen E GE   Somlyo Avril V AV   Derewenda Zygmunt S ZS  

Acta crystallographica. Section D, Biological crystallography 20130119 Pt 2


Members of the RSK family of kinases constitute attractive targets for drug design, but a lack of structural information regarding the mechanism of selective inhibitors impedes progress in this field. The crystal structure of the N-terminal kinase domain (residues 45-346) of mouse RSK2, or RSK2(NTKD), has recently been described in complex with one of only two known selective inhibitors, a rare naturally occurring flavonol glycoside, kaempferol 3-O-(3'',4''-di-O-acetyl-α-L-rhamnopyranoside), kno  ...[more]

Similar Datasets

| S-EPMC3462495 | biostudies-literature
| S-EPMC3596281 | biostudies-literature
| S-EPMC1698666 | biostudies-literature
| S-EPMC3683371 | biostudies-literature
| S-EPMC3920941 | biostudies-literature
| S-EPMC6635457 | biostudies-literature
| S-EPMC8488253 | biostudies-literature
| S-EPMC10758423 | biostudies-literature
| S-EPMC6195510 | biostudies-literature
| S-EPMC3712578 | biostudies-literature